title: Characterization of attenuated Theileria annulata vaccines from Spain and the Sudan.
abstract: Theileriosis caused by Theileria annulata can be effectively prevented by vaccination with attenuated, cultured schizonts. Although these attenuated vaccines have been applied for a long time, not much is known about the fate of the vaccine strain in the field. Here, two experimental Spanish vaccine strains originating in Cádiz and Cáceres, and one Sudanese strain are studied to address the development of a carrier status and the infectivity for Hyalomma ticks. Moreover, the heterogeneity of the merozoite surface protein, Tams1, was analyzed in search for an attenuation marker. Using the sensitive reverse line blot (RLB) hybridization, the development of a low level carrier status was demonstrated in the Cáceres and Sudanese line vaccinated calves. Although no signal was detected in the Cádiz line vaccinated calves, seroconversion against the schizont stage was observed, as it was in all other calves. The experimental transmission of T. annulata by Hyalomma ticks to naïve calves was unsuccessful for all cell line inoculated calves. Tams1 heterogeneity indicated a clonal selection of parasites during the process of attenuation, but the Tams1 sequence itself has no connection with the attenuation status. In conclusion, a carrier status develops in attenuated schizont culture vaccinated calves, but is not infective for Hyalomma ticks. Based on these data, the risk for spread of the vaccine strains in the field may be very low.
authors.affiliation: Department of Parasitology and Tropical Veterinary Medicine, Faculty of Veterinary Medicine, Utrecht University.
authors.forename: M J
authors.initials: MJ
authors.lastname: Gubbels
authors.forename: J
authors.initials: J
authors.lastname: Viseras
authors.forename: M A
authors.initials: MA
authors.lastname: Habela
authors.forename: F
authors.initials: F
authors.lastname: Jongejan
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood*; D000917:Antibody Formation; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology* / Q000517:prevention & control; D004275:DNA, Ribosomal / Q000235:genetics; D005260:Female; D018884:Ixodes / Q000469:parasitology; D008969:Molecular Sequence Data; D016052:Protozoan Vaccines; D016053:RNA, Protozoan / Q000235:genetics; D012337:RNA, Ribosomal, 18S / Q000235:genetics; D011994:Recombinant Proteins / Q000276:immunology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D013030:Spain; D013397:Sudan; D016796:Theileria annulata / Q000235:genetics / Q000276:immunology*; D013801:Theileriasis / Q000276:immunology* / Q000517:prevention & control; D017282:Tick-Borne Diseases / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary; D014613:Vaccines, Attenuated
chemical_list: D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D004275:DNA, Ribosomal; D016052:Protozoan Vaccines; D016053:RNA, Protozoan; D012337:RNA, Ribosomal, 18S; D011994:Recombinant Proteins; C113538:Tams1 antigen; D014613:Vaccines, Attenuated